Form 4: Biohaven Director Kishan Mehta Acquires Stock Options
SEC Form 4
Director Kishan Mehta acquired 31,716 stock options in Biohaven Ltd. on May 5, 2025.
Summary
- Kishan Mehta, a director of Biohaven Ltd., acquired 31,716 stock options on May 5, 2025.
- The exercise price of these options is $22.62.
- The options vest fully on the earlier of May 5, 2026, or the date of the 2026 Annual Meeting of Shareholders, contingent upon continuous service with the issuer.
- The options expire on May 5, 2035.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock option grants, which is neutral in sentiment.
Industry Context
This is a standard Form 4 filing, reflecting a change in beneficial ownership by a company insider. Option grants are a common form of executive compensation in the biotechnology industry.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/05/2025 | Date of transaction: Kishan Mehta acquired stock options. |
| 05/05/2026 | Earliest vesting date for the stock options. |
| 05/05/2035 | Expiration date for the stock options. |
Keywords
stock options, Biohaven, director, acquisition, BHVN, Kishan Mehta
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.